May 04, 2026 05:29 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jolt to TMC! Supreme Court rejects plea challenging central staff deployment at Bengal counting centres | Bangladesh MP warns of refugee crisis if BJP wins West Bengal polls | Diplomatic row: Bangladesh summons Indian envoy over Himanta Biswa Sarma remarks | Supreme Court grants Pawan Khera anticipatory bail in case over allegations against Himanta Biswa Sarma's wife | ‘Not necessary to humiliate me with arrest’: Pawan Khera to SC over remarks on Himanta Biswa Sarma’s wife | ‘Let’s not choose for people capable of choosing’: Supreme Court to Centre on teen pregnancy termination | I-PAC co-founder Vinesh Chandel gets bail after Bengal polls conclude | Exit Polls Give Bengal to BJP—But One Survey Begs to Differ | Big defence push: Rajnath Singh to hold high-stakes talks with Italy’s Defence Minister | “Voting without fear”: PM Modi hails record turnout in West Bengal polls
Covaxin | WHO Approval
Image Credit: UNICEF

Chinese vax took longer than COVAXIN to get approval, says WHO

| @indiablooms | Nov 04, 2021, at 06:20 am

New Delhi/IBNS: Covaxin did not take the longest to get the World Health Organization's (WHO) approval for Emergency Use Listing, according to Chief Scientist Dr Soumya Swaminathan.

Dismissing criticisms that the UN health body held up the approval to India-made Covaxin but readily cleared Chinese jabs, she said China-made Sinopharm and Sinovac vaccines took between 150-165 days to secure the WHO's approval, reported NDTV.

On average vaccines were given Emergency Use Listing approval in 50-60 days but some took up to 165 days.

"Covaxin is somewhere in the middle, it took somewhere between 90 and 100 days," Dr Swaminathan said.

The WHO panel tasked with clearing vaccines for Emergency Use Listing met last week and sought more information. "The committee met again today and were very satisfied," she said.

She said there are 13 more vaccines that are still awaiting the global health body's approval.

Since WHO Emergency Use Listed vaccines are a benchmark of safety and efficacy, many countries accept them, she said, adding that the clearance would have a significant impact on India's travel plans.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.